skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

This content will become publicly available on August 5, 2020

Title: Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine

Authors:
ORCiD logo [1];  [1];  [2];  [3]; ORCiD logo [4]
  1. Department of PharmacologyYale University School of Medicine New Haven Connecticut
  2. Laboratory of Biochemical Pharmacology, Department of Pediatrics, Center for AIDS ResearchEmory University School of Medicine Atlanta Georgia
  3. Department of Pharmacology and ToxicologyUniversity of Texas Medical Branch Galveston Texas, Sealy Center for Structural BiologyUniversity of Texas Medical Branch Galveston Texas
  4. Department of PharmacologyYale University School of Medicine New Haven Connecticut, Department of Molecular Biophysics and BiochemistryYale University School of Medicine New Haven Connecticut
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1547084
Grant/Contract Number:  
DE‐AC02‐06CH11357
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Protein Science
Additional Journal Information:
Journal Name: Protein Science; Journal ID: ISSN 0961-8368
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Bertoletti, Nicole, Chan, Albert H., Schinazi, Raymond F., Yin, Y. Whitney, and Anderson, Karen S. Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine. United Kingdom: N. p., 2019. Web. doi:10.1002/pro.3681.
Bertoletti, Nicole, Chan, Albert H., Schinazi, Raymond F., Yin, Y. Whitney, & Anderson, Karen S. Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine. United Kingdom. doi:10.1002/pro.3681.
Bertoletti, Nicole, Chan, Albert H., Schinazi, Raymond F., Yin, Y. Whitney, and Anderson, Karen S. Tue . "Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine". United Kingdom. doi:10.1002/pro.3681.
@article{osti_1547084,
title = {Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine},
author = {Bertoletti, Nicole and Chan, Albert H. and Schinazi, Raymond F. and Yin, Y. Whitney and Anderson, Karen S.},
abstractNote = {},
doi = {10.1002/pro.3681},
journal = {Protein Science},
number = ,
volume = ,
place = {United Kingdom},
year = {2019},
month = {8}
}

Journal Article:
Free Publicly Available Full Text
This content will become publicly available on August 5, 2020
Publisher's Version of Record

Save / Share:

Works referenced in this record:

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158